THINKMD Finalizes $4 Million Equity Investment

Dec. 15, 2021,

THINKMD, a medical technology company, finalized a $4 million equity investment round in October. This injection of capital will enable the company to enter its next phase of growth. Investors in the round include Save the Children Federation, Save the Children Impact Fund Ltd. and the Sorenson Impact Foundation. 

“Now more than ever, we need to enable a frontline healthcare workforce with the tools to offer clinical quality to those most often left behind in the health response,” said Chris Powell, THINKMD’s CEO. “We feel privileged that global health leaders recognize that THINKMD’s solution can help close some of the gap.”

President and CEO of Save the Children, Janti Soeripto, said, “The power of innovation to improve health outcomes for children cannot be overstated. In the countries where we work, quality healthcare is often restricted due to the shortage of healthcare providers or limitations on healthcare delivery. We are excited to partner with THINKMD to help achieve a future where no child under five dies of preventable causes.”

This new funding comes on the heels of a $2.3 million technology development grant by the Bill & Melinda Gates Foundation announced in September.   The grant will also accelerate the company’s machine learning and data analytics efforts, as well as field-based implementations of THINKMD’s solutions to demonstrate scalability and impact.

THINKMD, a VTTA Member, is a social impact, mission-driven technology company focused on making its clinical intelligence technology universally available so that anyone, anywhere can make better healthcare decisions for themselves and their communities. The company’s solutions are currently active in 10 countries and help any user identify how sick a person is, what illness they may have and what next steps to take. Validation studies have demonstrated that THINKMD’s clinical assessments and triage recommendations correlate up to 95% with those of healthcare professionals.